[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medipharm Labs Corp 151 John Street Barrie ON L4N 2L1 CAN

https://www.medipharmlabs.com P: 705-719-7425

Sector:

Medical

Description:

MediPharm Labs Corp and its subsidiaries produce cannabis, purified and pharmaceutical-like cannabis extracts, related derivative products, and cannabis-related medical information and services. Its operating subsidiaries hold cultivation, standard processing, and sale licences under the Cannabis Act (Canada), allowing the cultivation, sale, and distribution of cannabis oil, extracts, edibles, topicals, dried and fresh cannabis, and derivatives to authorized purchasers. Its subsidiary provides clinic services to Canadian patients requiring medical cannabis education and prescriptions. The company operates in one reportable segment, the production and sales of cannabis flower, and generates maximum revenue from Canada, with additional international sales.

Key Statistics

Overview:

Market Capitalization, $K 27,616
Shares Outstanding, K 424,864
% of Institutional Shareholders 0.34%

Financials:

Annual Sales, $ 45,124 K
Annual Net Income, $ -8,267 K
Last Quarter Sales, $ 8,963 K
Last Quarter Net Income, $ -867 K

Growth:

1-Year Return 7.69%
3-Year Return 8.33%
5-Year Return -85.23%
5-Year Revenue Growth 4.61%

Per-Share Information:

Most Recent Earnings 0.00 on 05/13/26
Next Earnings Date 03/26/25
Earnings Per Share ttm -0.02
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -35.34%
Dividend Payout Ratio 0.00%
Most Recent Split 1-2 on 10/04/18

LABS.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -22.33%
Return-on-Assets % -18.28%
Profit Margin % -18.32%
Debt/Equity N/A
Price/Sales 0.63
Price/Book 0.79
Book Value/Share 0.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.